Lv2
146 积分 2023-07-20 加入
Efficacy of deucravacitinib and guselkumab in a patient with psoriasis who had experienced multiple failures of biologics: a case report
18小时前
已完结
Safety and efficacy of dual tyrosine kinase 2 inhibitor and monoclonal antibody therapy for psoriasis and psoriatic arthritis
19小时前
已完结
Effectiveness of deucravacitinib for genital, nail and scalp lesions in patients with psoriasis: a 24-week real-world study
19小时前
已完结
Definition of Severity and Relapse for Vitiligo
3天前
已完结
TYK2 and IL‐23 Pathway Therapies in Psoriasis: Associations With IL‐6, Tryptophan Metabolism, and Depressive Symptoms
5天前
已完结
Real‐Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate‐To‐Severe Atopic Dermatitis
2个月前
已完结
Efficacy of abrocitinib in patients with moderate-to-severe head and neck dermatitis
2个月前
已完结
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
2个月前
已完结
423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial
3个月前
已完结
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
3个月前
已完结
皖公网安备34019202002308
